Table of Contents 1 Fibromyalgia Treatment Market Overview 1.1 Product Overview and Scope of Fibromyalgia Treatment 1.2 Fibromyalgia Treatment Segment by Type 1.2.1 Global Fibromyalgia Treatment Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Antidepressants 1.2.3 Anticonvulsants 1.2.4 Muscle Relaxants 1.2.5 Narcotic Analgesics 1.2.6 Non-narcotic Analgesics 1.3 Fibromyalgia Treatment Segment by Application 1.3.1 Fibromyalgia Treatment Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospitals Pharmacies 1.3.3 Clinic Pharmacy 1.3.4 Retail Drug Stores 1.3.5 Online Pharmacies 1.4 Global Fibromyalgia Treatment Market Size Estimates and Forecasts 1.4.1 Global Fibromyalgia Treatment Revenue 2015-2026 1.4.2 Global Fibromyalgia Treatment Sales 2015-2026 1.4.3 Fibromyalgia Treatment Market Size by Region: 2020 Versus 2026 2 Global Fibromyalgia Treatment Market Competition by Manufacturers 2.1 Global Fibromyalgia Treatment Sales Market Share by Manufacturers (2015-2020) 2.2 Global Fibromyalgia Treatment Revenue Share by Manufacturers (2015-2020) 2.3 Global Fibromyalgia Treatment Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Fibromyalgia Treatment Manufacturing Sites, Area Served, Product Type 2.5 Fibromyalgia Treatment Market Competitive Situation and Trends 2.5.1 Fibromyalgia Treatment Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Fibromyalgia Treatment Players (Opinion Leaders) 3 Fibromyalgia Treatment Retrospective Market Scenario by Region 3.1 Global Fibromyalgia Treatment Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Fibromyalgia Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Fibromyalgia Treatment Market Facts & Figures by Country 3.3.1 North America Fibromyalgia Treatment Sales by Country 3.3.2 North America Fibromyalgia Treatment Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Fibromyalgia Treatment Market Facts & Figures by Country 3.4.1 Europe Fibromyalgia Treatment Sales by Country 3.4.2 Europe Fibromyalgia Treatment Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Fibromyalgia Treatment Market Facts & Figures by Region 3.5.1 Asia Pacific Fibromyalgia Treatment Sales by Region 3.5.2 Asia Pacific Fibromyalgia Treatment Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Fibromyalgia Treatment Market Facts & Figures by Country 3.6.1 Latin America Fibromyalgia Treatment Sales by Country 3.6.2 Latin America Fibromyalgia Treatment Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Fibromyalgia Treatment Market Facts & Figures by Country 3.7.1 Middle East and Africa Fibromyalgia Treatment Sales by Country 3.7.2 Middle East and Africa Fibromyalgia Treatment Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Fibromyalgia Treatment Historic Market Analysis by Type 4.1 Global Fibromyalgia Treatment Sales Market Share by Type (2015-2020) 4.2 Global Fibromyalgia Treatment Revenue Market Share by Type (2015-2020) 4.3 Global Fibromyalgia Treatment Price Market Share by Type (2015-2020) 4.4 Global Fibromyalgia Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Fibromyalgia Treatment Historic Market Analysis by Application 5.1 Global Fibromyalgia Treatment Sales Market Share by Application (2015-2020) 5.2 Global Fibromyalgia Treatment Revenue Market Share by Application (2015-2020) 5.3 Global Fibromyalgia Treatment Price by Application (2015-2020) 6 Company Profiles and Key Figures in Fibromyalgia Treatment Business 6.1 Eli Lilly and Company 6.1.1 Corporation Information 6.1.2 Eli Lilly and Company Description, Business Overview and Total Revenue 6.1.3 Eli Lilly and Company Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Eli Lilly and Company Products Offered 6.1.5 Eli Lilly and Company Recent Development 6.2 Pfizer 6.2.1 Pfizer Fibromyalgia Treatment Production Sites and Area Served 6.2.2 Pfizer Description, Business Overview and Total Revenue 6.2.3 Pfizer Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Pfizer Products Offered 6.2.5 Pfizer Recent Development 6.3 Novartis AG 6.3.1 Novartis AG Fibromyalgia Treatment Production Sites and Area Served 6.3.2 Novartis AG Description, Business Overview and Total Revenue 6.3.3 Novartis AG Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Novartis AG Products Offered 6.3.5 Novartis AG Recent Development 6.4 Allergan 6.4.1 Allergan Fibromyalgia Treatment Production Sites and Area Served 6.4.2 Allergan Description, Business Overview and Total Revenue 6.4.3 Allergan Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Allergan Products Offered 6.4.5 Allergan Recent Development 6.5 Aptinyx 6.5.1 Aptinyx Fibromyalgia Treatment Production Sites and Area Served 6.5.2 Aptinyx Description, Business Overview and Total Revenue 6.5.3 Aptinyx Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Aptinyx Products Offered 6.5.5 Aptinyx Recent Development 6.6 Prismic Pharmaceuticals 6.6.1 Prismic Pharmaceuticals Fibromyalgia Treatment Production Sites and Area Served 6.6.2 Prismic Pharmaceuticals Description, Business Overview and Total Revenue 6.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Prismic Pharmaceuticals Products Offered 6.6.5 Prismic Pharmaceuticals Recent Development 6.7 Innovative Med Concepts 6.6.1 Innovative Med Concepts Fibromyalgia Treatment Production Sites and Area Served 6.6.2 Innovative Med Concepts Description, Business Overview and Total Revenue 6.6.3 Innovative Med Concepts Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Innovative Med Concepts Products Offered 6.7.5 Innovative Med Concepts Recent Development 6.8 Intec Pharma Ltd. 6.8.1 Intec Pharma Ltd. Fibromyalgia Treatment Production Sites and Area Served 6.8.2 Intec Pharma Ltd. Description, Business Overview and Total Revenue 6.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Intec Pharma Ltd. Products Offered 6.8.5 Intec Pharma Ltd. Recent Development 6.9 Astellas Pharma 6.9.1 Astellas Pharma Fibromyalgia Treatment Production Sites and Area Served 6.9.2 Astellas Pharma Description, Business Overview and Total Revenue 6.9.3 Astellas Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Astellas Pharma Products Offered 6.9.5 Astellas Pharma Recent Development 6.10 Savella 6.10.1 Savella Fibromyalgia Treatment Production Sites and Area Served 6.10.2 Savella Description, Business Overview and Total Revenue 6.10.3 Savella Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Savella Products Offered 6.10.5 Savella Recent Development 6.11 Sun Pharmaceutical Industries 6.11.1 Sun Pharmaceutical Industries Fibromyalgia Treatment Production Sites and Area Served 6.11.2 Sun Pharmaceutical Industries Fibromyalgia Treatment Description, Business Overview and Total Revenue 6.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Sun Pharmaceutical Industries Products Offered 6.11.5 Sun Pharmaceutical Industries Recent Development 6.12 Mylan NV 6.12.1 Mylan NV Fibromyalgia Treatment Production Sites and Area Served 6.12.2 Mylan NV Fibromyalgia Treatment Description, Business Overview and Total Revenue 6.12.3 Mylan NV Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Mylan NV Products Offered 6.12.5 Mylan NV Recent Development 6.13 Teva Pharmaceutical Industries 6.13.1 Teva Pharmaceutical Industries Fibromyalgia Treatment Production Sites and Area Served 6.13.2 Teva Pharmaceutical Industries Fibromyalgia Treatment Description, Business Overview and Total Revenue 6.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Teva Pharmaceutical Industries Products Offered 6.13.5 Teva Pharmaceutical Industries Recent Development 6.14 Daiichi Sankyo 6.14.1 Daiichi Sankyo Fibromyalgia Treatment Production Sites and Area Served 6.14.2 Daiichi Sankyo Fibromyalgia Treatment Description, Business Overview and Total Revenue 6.14.3 Daiichi Sankyo Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Daiichi Sankyo Products Offered 6.14.5 Daiichi Sankyo Recent Development 6.15 Forest Pharmaceuticals 6.15.1 Forest Pharmaceuticals Fibromyalgia Treatment Production Sites and Area Served 6.15.2 Forest Pharmaceuticals Fibromyalgia Treatment Description, Business Overview and Total Revenue 6.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Forest Pharmaceuticals Products Offered 6.15.5 Forest Pharmaceuticals Recent Development 6.16 Meiji Seika Pharma 6.16.1 Meiji Seika Pharma Fibromyalgia Treatment Production Sites and Area Served 6.16.2 Meiji Seika Pharma Fibromyalgia Treatment Description, Business Overview and Total Revenue 6.16.3 Meiji Seika Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.16.4 Meiji Seika Pharma Products Offered 6.16.5 Meiji Seika Pharma Recent Development 6.17 Tonix Pharmaceuticals 6.17.1 Tonix Pharmaceuticals Fibromyalgia Treatment Production Sites and Area Served 6.17.2 Tonix Pharmaceuticals Fibromyalgia Treatment Description, Business Overview and Total Revenue 6.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.17.4 Tonix Pharmaceuticals Products Offered 6.17.5 Tonix Pharmaceuticals Recent Development 6.18 Theravance Biopharma 6.18.1 Theravance Biopharma Fibromyalgia Treatment Production Sites and Area Served 6.18.2 Theravance Biopharma Fibromyalgia Treatment Description, Business Overview and Total Revenue 6.18.3 Theravance Biopharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2015-2020) 6.18.4 Theravance Biopharma Products Offered 6.18.5 Theravance Biopharma Recent Development 7 Fibromyalgia Treatment Manufacturing Cost Analysis 7.1 Fibromyalgia Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Fibromyalgia Treatment 7.4 Fibromyalgia Treatment Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Fibromyalgia Treatment Distributors List 8.3 Fibromyalgia Treatment Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Fibromyalgia Treatment Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Fibromyalgia Treatment by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Fibromyalgia Treatment by Type (2021-2026) 10.2 Fibromyalgia Treatment Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Fibromyalgia Treatment by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Fibromyalgia Treatment by Application (2021-2026) 10.3 Fibromyalgia Treatment Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Fibromyalgia Treatment by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Fibromyalgia Treatment by Region (2021-2026) 10.4 North America Fibromyalgia Treatment Estimates and Projections (2021-2026) 10.5 Europe Fibromyalgia Treatment Estimates and Projections (2021-2026) 10.6 Asia Pacific Fibromyalgia Treatment Estimates and Projections (2021-2026) 10.7 Latin America Fibromyalgia Treatment Estimates and Projections (2021-2026) 10.8 Middle East and Africa Fibromyalgia Treatment Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Fibromyalgia Treatment Sales (KG) Growth Rate Comparison by Type (2015-2026) Table 2. Global Fibromyalgia Treatment Sales (KG) Comparison by Application: 2020 VS 2026 Table 3. Global Fibromyalgia Treatment Market Size by Type (KG) (US$ Million) (2020 VS 2026) Table 4. Global Key Fibromyalgia Treatment Manufacturers Covered in This Study Table 5. Global Fibromyalgia Treatment Sales (KG) by Manufacturers (2015-2020) Table 6. Global Fibromyalgia Treatment Sales Share by Manufacturers (2015-2020) Table 7. Global Fibromyalgia Treatment Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Fibromyalgia Treatment Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Fibromyalgia Treatment Average Price (USD/KG) of Key Manufacturers (2015-2020) Table 10. Manufacturers Fibromyalgia Treatment Sales Sites and Area Served Table 11. Manufacturers Fibromyalgia Treatment Product Types Table 12. Global Fibromyalgia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Fibromyalgia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Fibromyalgia Treatment Players Table 16. Global Fibromyalgia Treatment Sales (KG) by Region (2015-2020) Table 17. Global Fibromyalgia Treatment Sales Market Share by Region (2015-2020) Table 18. Global Fibromyalgia Treatment Revenue (Million US$) by Region (2015-2020) Table 19. Global Fibromyalgia Treatment Revenue Market Share by Region (2015-2020) Table 20. North America Fibromyalgia Treatment Sales by Country (2015-2020) (KG) Table 21. North America Fibromyalgia Treatment Sales Market Share by Country (2015-2020) Table 22. North America Fibromyalgia Treatment Revenue by Country (2015-2020) (US$ Million) Table 23. North America Fibromyalgia Treatment Revenue Market Share by Country (2015-2020) Table 24. Europe Fibromyalgia Treatment Sales by Country (2015-2020) (KG) Table 25. Europe Fibromyalgia Treatment Sales Market Share by Country (2015-2020) Table 26. Europe Fibromyalgia Treatment Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Fibromyalgia Treatment Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Fibromyalgia Treatment Sales by Region (2015-2020) (KG) Table 29. Asia Pacific Fibromyalgia Treatment Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Fibromyalgia Treatment Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Fibromyalgia Treatment Revenue Market Share by Region (2015-2020) Table 32. Latin America Fibromyalgia Treatment Sales by Country (2015-2020) (KG) Table 33. Latin America Fibromyalgia Treatment Sales Market Share by Country (2015-2020) Table 34. Latin America Fibromyalgia Treatment Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Fibromyalgia Treatment Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Fibromyalgia Treatment Sales by Country (2015-2020) (KG) Table 37. Middle East and Africa Fibromyalgia Treatment Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Fibromyalgia Treatment Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Fibromyalgia Treatment Revenue Market Share by Country (2015-2020) Table 40. Global Fibromyalgia Treatment Sales (KG) by Type (2015-2020) Table 41. Global Fibromyalgia Treatment Sales Share by Type (2015-2020) Table 42. Global Fibromyalgia Treatment Revenue (Million US$) by Type (2015-2020) Table 43. Global Fibromyalgia Treatment Revenue Share by Type (2015-2020) Table 44. Global Fibromyalgia Treatment Price (USD/KG) by Type (2015-2020) Table 45. Global Fibromyalgia Treatment Sales (KG) by Application (2015-2020) Table 46. Global Fibromyalgia Treatment Sales Market Share by Application (2015-2020) Table 47. Global Fibromyalgia Treatment Sales Growth Rate by Application (2015-2020) Table 48. Eli Lilly and Company Fibromyalgia Treatment Corporation Information Table 49. Eli Lilly and Company Description and Business Overview Table 50. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 51. Eli Lilly and Company Main Product Table 52. Eli Lilly and Company Recent Development Table 53. Pfizer Fibromyalgia Treatment Corporation Information Table 54. Pfizer Corporation Information Table 55. Pfizer Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 56. Pfizer Main Product Table 57. Pfizer Recent Development Table 58. Novartis AG Fibromyalgia Treatment Corporation Information Table 59. Novartis AG Corporation Information Table 60. Novartis AG Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 61. Novartis AG Main Product Table 62. Novartis AG Recent Development Table 63. Allergan Fibromyalgia Treatment Corporation Information Table 64. Allergan Corporation Information Table 65. Allergan Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 66. Allergan Main Product Table 67. Allergan Recent Development Table 68. Aptinyx Fibromyalgia Treatment Corporation Information Table 69. Aptinyx Corporation Information Table 70. Aptinyx Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 71. Aptinyx Main Product Table 72. Aptinyx Recent Development Table 73. Prismic Pharmaceuticals Fibromyalgia Treatment Corporation Information Table 74. Prismic Pharmaceuticals Corporation Information Table 75. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 76. Prismic Pharmaceuticals Main Product Table 77. Prismic Pharmaceuticals Recent Development Table 78. Innovative Med Concepts Fibromyalgia Treatment Corporation Information Table 79. Innovative Med Concepts Corporation Information Table 80. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 81. Innovative Med Concepts Main Product Table 82. Innovative Med Concepts Recent Development Table 83. Intec Pharma Ltd. Fibromyalgia Treatment Corporation Information Table 84. Intec Pharma Ltd. Corporation Information Table 85. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 86. Intec Pharma Ltd. Main Product Table 87. Intec Pharma Ltd. Recent Development Table 88. Astellas Pharma Fibromyalgia Treatment Corporation Information Table 89. Astellas Pharma Corporation Information Table 90. Astellas Pharma Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 91. Astellas Pharma Main Product Table 92. Astellas Pharma Recent Development Table 93. Savella Fibromyalgia Treatment Corporation Information Table 94. Savella Corporation Information Table 95. Savella Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 96. Savella Main Product Table 97. Savella Recent Development Table 98. Sun Pharmaceutical Industries Fibromyalgia Treatment Corporation Information Table 99. Sun Pharmaceutical Industries Corporation Information Table 100. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 101. Sun Pharmaceutical Industries Main Product Table 102. Sun Pharmaceutical Industries Recent Development Table 103. Mylan NV Fibromyalgia Treatment Corporation Information Table 104. Mylan NV Corporation Information Table 105. Mylan NV Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 106. Mylan NV Main Product Table 107. Mylan NV Recent Development Table 108. Teva Pharmaceutical Industries Fibromyalgia Treatment Corporation Information Table 109. Teva Pharmaceutical Industries Corporation Information Table 110. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 111. Teva Pharmaceutical Industries Main Product Table 112. Teva Pharmaceutical Industries Recent Development Table 113. Daiichi Sankyo Fibromyalgia Treatment Corporation Information Table 114. Daiichi Sankyo Corporation Information Table 115. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 116. Daiichi Sankyo Main Product Table 117. Daiichi Sankyo Recent Development Table 118. Forest Pharmaceuticals Fibromyalgia Treatment Corporation Information Table 119. Forest Pharmaceuticals Corporation Information Table 120. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 121. Forest Pharmaceuticals Main Product Table 122. Forest Pharmaceuticals Recent Development Table 123. Meiji Seika Pharma Fibromyalgia Treatment Corporation Information Table 124. Meiji Seika Pharma Corporation Information Table 125. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 126. Meiji Seika Pharma Main Product Table 127. Meiji Seika Pharma Recent Development Table 128. Tonix Pharmaceuticals Fibromyalgia Treatment Corporation Information Table 129. Tonix Pharmaceuticals Corporation Information Table 130. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 131. Tonix Pharmaceuticals Main Product Table 132. Tonix Pharmaceuticals Recent Development Table 133. Theravance Biopharma Fibromyalgia Treatment Corporation Information Table 134. Theravance Biopharma Corporation Information Table 135. Theravance Biopharma Fibromyalgia Treatment Sales (KG), Revenue (Million US$), Price (USD/KG) and Gross Margin (2015-2020) Table 136. Theravance Biopharma Main Product Table 137. Theravance Biopharma Recent Development Table 138. Sales Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Fibromyalgia Treatment Distributors List Table 141. Fibromyalgia Treatment Customers List Table 142. Market Key Trends Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 144. Key Challenges Table 145. Global Fibromyalgia Treatment Sales (KG) Forecast by Type (2021-2026) Table 146. Global Fibromyalgia Treatment Sales Market Share Forecast by Type (2021-2026) Table 147. Global Fibromyalgia Treatment Revenue (Million US$) Forecast by Type (2021-2026) Table 148. Global Fibromyalgia Treatment Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 149. Global Fibromyalgia Treatment Sales (KG) Forecast by Application (2021-2026) Table 150. Global Fibromyalgia Treatment Revenue (Million US$) Forecast by Application (2021-2026) Table 151. Global Fibromyalgia Treatment Sales (KG) Forecast by Region (2021-2026) Table 152. Global Fibromyalgia Treatment Sales Market Share Forecast by Region (2021-2026) Table 153. Global Fibromyalgia Treatment Revenue Forecast by Region (2021-2026) (US$ Million) Table 154. Global Fibromyalgia Treatment Revenue Market Share Forecast by Region (2021-2026) Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Fibromyalgia Treatment Figure 2. Global Fibromyalgia Treatment Sales Market Share by Type: 2020 VS 2026 Figure 3. Antidepressants Product Picture Figure 4. Anticonvulsants Product Picture Figure 5. Muscle Relaxants Product Picture Figure 6. Narcotic Analgesics Product Picture Figure 7. Non-narcotic Analgesics Product Picture Figure 8. Global Fibromyalgia Treatment Consumption Market Share by Application: 2020 VS 2026 Figure 9. Hospitals Pharmacies Figure 10. Clinic Pharmacy Figure 11. Retail Drug Stores Figure 12. Online Pharmacies Figure 13. Global Fibromyalgia Treatment Market Size 2015-2026 (US$ Million) Figure 14. Global Fibromyalgia Treatment Sales Capacity (KG) (2015-2026) Figure 15. Global Fibromyalgia Treatment Market Size Market Share by Region: 2020 Versus 2026 Figure 16. Fibromyalgia Treatment Sales Share by Manufacturers in 2020 Figure 17. Global Fibromyalgia Treatment Revenue Share by Manufacturers in 2019 Figure 18. The Global 5 and 10 Largest Players: Market Share by Fibromyalgia Treatment Revenue in 2019 Figure 19. Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Fibromyalgia Treatment Sales Market Share by Region (2015-2020) Figure 21. Global Fibromyalgia Treatment Sales Market Share by Region in 2019 Figure 22. Global Fibromyalgia Treatment Revenue Market Share by Region (2015-2020) Figure 23. Global Fibromyalgia Treatment Revenue Market Share by Region in 2019 Figure 24. North America Fibromyalgia Treatment Sales Market Share by Country in 2019 Figure 25. North America Fibromyalgia Treatment Revenue Market Share by Country in 2019 Figure 26. U.S. Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 27. U.S. Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Canada Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 29. Canada Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. Europe Fibromyalgia Treatment Sales Market Share by Country in 2019 Figure 31. Europe Fibromyalgia Treatment Revenue Market Share by Country in 2019 Figure 32. Germany Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 33. Germany Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. France Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 35. France Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. U.K. Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 37. U.K. Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Italy Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 39. Italy Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Russia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 41. Russia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Asia Pacific Fibromyalgia Treatment Sales Market Share by Region in 2019 Figure 43. Asia Pacific Fibromyalgia Treatment Revenue Market Share by Region in 2019 Figure 44. China Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 45. China Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. Japan Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 47. Japan Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. South Korea Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 49. South Korea Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. India Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 51. India Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Australia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 53. Australia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Taiwan Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 55. Taiwan Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Indonesia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 57. Indonesia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Thailand Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 59. Thailand Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Malaysia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 61. Malaysia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Philippines Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 63. Philippines Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Vietnam Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 65. Vietnam Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Latin America Fibromyalgia Treatment Sales Market Share by Country in 2019 Figure 67. Latin America Fibromyalgia Treatment Revenue Market Share by Country in 2019 Figure 68. Mexico Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 69. Mexico Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Brazil Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 71. Brazil Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Argentina Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 73. Argentina Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Middle East and Africa Fibromyalgia Treatment Sales Market Share by Country in 2019 Figure 75. Middle East and Africa Fibromyalgia Treatment Revenue Market Share by Country in 2019 Figure 76. Turkey Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 77. Turkey Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Saudi Arabia Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 79. Saudi Arabia Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. U.A.E Fibromyalgia Treatment Sales Growth Rate (2015-2020) (KG) Figure 81. U.A.E Fibromyalgia Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Sales Market Share of Fibromyalgia Treatment by Type (2015-2020) Figure 83. Sales Market Share of Fibromyalgia Treatment by Type in 2019 Figure 84. Revenue Share of Fibromyalgia Treatment by Type (2015-2020) Figure 85. Revenue Market Share of Fibromyalgia Treatment by Type in 2019 Figure 86. Global Fibromyalgia Treatment Sales Growth by Type (2015-2020) (KG) Figure 87. Global Fibromyalgia Treatment Sales Market Share by Application (2015-2020) Figure 88. Global Fibromyalgia Treatment Sales Market Share by Application in 2019 Figure 89. Global Revenue Share of Fibromyalgia Treatment by Application (2015-2020) Figure 90. Global Revenue Share of Fibromyalgia Treatment by Application in 2020 Figure 91. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Aptinyx Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Prismic Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Innovative Med Concepts Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Intec Pharma Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Savella Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Mylan NV Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. Forest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. Meiji Seika Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. Tonix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 108. Theravance Biopharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. Price Trend of Key Raw Materials Figure 110. Manufacturing Cost Structure of Fibromyalgia Treatment Figure 111. Manufacturing Process Analysis of Fibromyalgia Treatment Figure 112. Fibromyalgia Treatment Industrial Chain Analysis Figure 113. Channels of Distribution Figure 114. Distributors Profiles Figure 115. Porter's Five Forces Analysis Figure 116. North America Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026) Figure 117. North America Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Europe Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026) Figure 119. Europe Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Latin America Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026) Figure 121. Latin America Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Middle East and Africa Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026) Figure 123. Middle East and Africa Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Asia Pacific Fibromyalgia Treatment Sales (KG) and Growth Rate Forecast (2021-2026) Figure 125. Asia Pacific Fibromyalgia Treatment Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 126. Bottom-up and Top-down Approaches for This Report Figure 127. Data Triangulation Figure 128. Key Executives Interviewed

Eli Lilly and Company Pfizer Novartis AG Allergan Aptinyx Prismic Pharmaceuticals Innovative Med Concepts Intec Pharma Ltd. Astellas Pharma Savella Sun Pharmaceutical Industries Mylan NV Teva Pharmaceutical Industries Daiichi Sankyo Forest Pharmaceuticals Meiji Seika Pharma Tonix Pharmaceuticals Theravance Biopharma